Name | 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine |
---|---|
Synonyms |
β-Acetyl-γ-O-hexadecyl-L-α-phosphatidylcholine
PAF Platelet-activating factor [(2R)-2-acetyloxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate 1-O-HEXADECYL-2-ACETYL-SN-GLYCERO-3-PHOSPHOCHOLINE 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine PAF Acether AcGEPC PAF(C16) MFCD00043214 (2R)-2-Acetoxy-3-(hexadecyloxy)propyl 2-(trimethylammonio)ethyl phosphate Ethanaminium, 2-[[[(2R)-2-(acetyloxy)-3-(hexadecyloxy)propoxy]hydroxyphosphinyl]oxy]-N,N,N-trimethyl-, inner salt |
Description | C16-PAF is an endogenous platelet-activating factor (PAF) and ligand for PAF receptors. C16-PAF is produced by inflammatory cells and a potent chemoattractant for polymorphonuclear neutrophils. C16-PAF induces increased vascular permeability. |
---|---|
Target |
Human Endogenous Metabolite |
Molecular Formula | C26H54NO7P |
---|---|
Molecular Weight | 523.683 |
Exact Mass | 523.363770 |
PSA | 103.93000 |
LogP | 3.94 |
Appearance | lyophilized powder |
Storage condition | −20°C |
Hazard Codes | Xn: Harmful; |
---|---|
Risk Phrases | 22-38-40-48/20/22 |
Safety Phrases | 36/37-24/25-22 |
RIDADR | UN 1888 6.1/PG 3 |
WGK Germany | 3 |
RTECS | EC6060000 |
Precursor 9 | |
---|---|
DownStream 0 |